Membranous Nephropathy - 29 Studies Found
Active, not recruiting |
: MEmbranous Nephropathy Trial Of Rituximab : Idiopathic Membranous Nephropathy : 2010-08-10 :
|
Withdrawn |
: Aliskiren in Patients With Idiopathic Membranous Nephropathy : Idiopathic Membranous Nephropathy : 2010-03-24 : Drug: Aliskiren Aliskiren dose will begin with 150mg per day and later up-titrated to the maximum availa |
Not yet recruiting |
: Adrenocorticotropic Hormone in Membranous Nephropathy : Membranous Nephropathy : 2017-01-17 : Drug: ACTHar for 6 months Other Names: |
Recruiting |
: Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy : MEMBRANOUS NEPHROPATHY : 2013-09-19 :
|
Active, not recruiting |
: Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy : Idiopathic Membranous Nephropathy : 2011-12-09 :
|
Completed |
: Rituximab in Membranous Nephropathy : Membranous Nephropathy : 2007-01-19 : Drug: Rituximab |
Active, not recruiting |
: Clinical Study of QingReMoShen Granule to Treat Idiopathic Membranous Nephropathy : Idiopathic Membranous Nephropathy : 2013-04-29 :
|
Completed |
: Rituximab in the Treatment of Idiopathic Membranous Nephropathy : Membranous Nephropathy : 2006-11-29 : Drug: Rituximab Patients will received rituximab 4 weekly doses of rituximab 375 mg/m2 at baseline. Pati |
Recruiting |
: Role of Anti-mouse PLA2R1 ELISA in Membranous Nephropathy : Membranous Nephropathy : 2014-07-22 : Procedure: Blood and urine analysis creatinine, albumin, blood electrolytes, proteinuria / creatinine in |
Completed |
: Treatment With Synthetic ACTH in High Risk Patients With Membranous Nephropathy : Idiopathic Membranous Nephropathy : 2008-06-09 : Drug: tetracosactide hexacetaat Intramuscular injections with tetracosactide hexacetaat (Synacthen Depot |